Moneycontrol PRO
LAMF
LAMF

Shasun Pharmaceuticals

Jump to
  • Bondholders of Suzlon Energy plan legal action post default: Report

  • Modi to address annual gala of USIBC next month

  • Market valuation of top-5 cos declines by Rs 38,969 cr

  • Buy Jubilant Foodworks, Wockhardt: Ashwani Gujral

  • Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

  • Hold Sun Pharma; target of Rs 845: ICICIDirect

  • Top buzzing midcap stocks to trade on January 29

  • India formulation; Maintain healthy growth: PrabhudasLilladher

  • Buy Sun Pharma; target of Rs 920:Edelweiss

  • Top buzzing midcap stocks to trade on December 23

  • Midcaps to shine; auto and pharma key themes: Dimensions

  • Buy Sun Pharmaceutical, says Sukhani

  • Like Strides Arcolab for long term, says Deepak Shenoy

  • Don‘t get carried away by bounce back, be cautious: Bhamre

  • Buy Coral Laboratories on dips, says Prakash Diwan

  • Super Six stocks that can boost your portfolio on Nov 23

  • Strides Shasun seek fresh approval to raise up to Rs 1500cr

  • Jubilant Life Sciences may test Rs 570, says Ajay Bodke

  • Sentiment to turn +ve for L&T in H2; buy IRB: Macquaire

  • Buy Sun Pharma; target of Rs 950: Angel Broking

  • Shasun Pharma up 2.5% on USFDA nod for muscle-relaxant drug

  • Shasun Pharma gets US FDA nod to market Carisoprodol

  • 15 quality stocks for Samvat 2072: AB Money

  • Stocks in news: Indiabulls Hsg, SpiceJet, Coal India, CESC

  • Neutral on Sun Pharmaceuticals : Reliance Securities

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347